The global burden of drug use and mental disorders

The Lancet

Volumn 382, Issue 9904, 2013, Pages 1540-1542

  Lynskey, Michael T ^a   Strang, John ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; CANNABIS; ILLICIT DRUG; METHAMPHETAMINE; OPIATE;

AFRICA SOUTH OF THE SAHARA; ALCOHOLISM; ATTRIBUTABLE RISK; CANNABIS ADDICTION; CAUSE OF DEATH; DEVELOPED COUNTRY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISABILITY; DISABILITY ADJUSTED LIFE YEAR; DRUG DEPENDENCE; DRUG USE; HEALTH CARE POLICY; HUMAN; KNOWLEDGE; MENTAL DISEASE; MENTAL HEALTH RESEARCH; MENTAL PATIENT; METHAMPHETAMINE DEPENDENCE; MORBIDITY; MORTALITY; NOTE; ONSET AGE; OPIATE ADDICTION; PASSIVE SMOKING; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; RISK FACTOR; SCHIZOPHRENIA; SUBSTANCE ABUSE; TOBACCO; TOBACCO DEPENDENCE; TRAFFIC ACCIDENT; UNCERTAINTY; UNITED STATES;

EID: 84887240096     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(13)61781-X     Document Type: Note

References (13)

1. Whiteford HA, Degenhardt L, Rehm J, et al. Global burden of di sease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet 2013; published online Aug 29. http://dx.doi.org/10.1016/S0140-6736(13)61611-6.
2. Degenhardt L, Whiteford HA, Ferrari AJ, et al. Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010. Lancet 2013; published online Aug 29. http://dx.doi.org/10.1016/S0140-6736(13)61530-5.
3. Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2224-60.
4. Murray CJ, Vos T, Lozano R, et al. Disability-adjusted life ye ars (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2197-223.
5. Vos T, Flaxman AD, Naghavi M, et al. Years lived with disabili ty (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2163-96.
6. Baxter AJ, Patton G, Scott KM, Degenhardt L, Whiteford HA. Global epidemiology of mental disorders: what are we missing? PLoS One 2013; 8: e65514.
7. Degenhardt L, Bucello C, Calabria B, et al. What data are avai lable on the extent of illicit drug use and dependence globally? Results of four systematic reviews. Drug Alcohol Depend 2011; 117: 85-101.
8. Demyttenaere K, Bruffaerts R, Posada-Villa J, et al. Prevalenc e, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. JAMA 2004; 291: 2581-90.
9. Frances AJ, Nardo JM. ICD-11 should not repeat the mistakes ma de by DSM-5. Br J Psychiatry 2013; 203: 1-2.
10. Degenhardt L, Hall W, Warner-Smith M, Lynskey M. Illicit drug use. In: Ezzati M, Lopez AD, Rodgers A, Murray CJL, eds. Comparative quantification of health risks: global and regional burden of disease attributable to selected major risk factors. Geneva: World Health Organization, 2004: 1109-75.
11. Degenhardt L, Hall WD, Lynskey M, et al. Should burden of dis ease estimates include cannabis use as a risk factor for psychosis? PLoS Med 2009; 6: e1000133.
12. Asbridge M, Hayden JA, Cartwright JL. Acute cannabis consumpt ion and motor vehicle collision risk: systematic review of observational studies and meta-analysis. BMJ 2012; 344: e536.
13. Strang J, Babor T, Caulkins J, Fischer B, Foxcroft D, Humphreys K. Drug policy and the public good: evidence for effective interventions. Lancet 2012; 379: 71-83.